Rice University leads development of innovative bioelectronic implant for obesity and diabetes

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.

3M names William Brown CEO

Name: William Brown New title: CEO, 3M Previous title: Executive chair of the board of directors, L3Harris Technologies William Brown has been appointed the next

March 12, 2024

How quality clinical monitoring oversight ensures the success of clinical trials – Pharmaceutical Technology

Share this article With the goal of ensuring issues with site misconduct are identified and addressed before problems occur, clinical monitoring is an essential cog

November 27, 2023

Semaglutide weight loss results linked to diabetes severity

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.